The Benefits of Genetic Addiction Risk Score (GARS?) Testing in Substance Use Disorder (SUD).

Blum K, Modestino EJ, Gondre-Lewis M, Chapman EJ, Neary J, Siwicki D, Baron D, Hauser M, Smith DE, Roy AK, Thanos PK, Steinberg B, McLaughlin T, Fried L, Barh D, Dunston GA, Badgaiyan RD. The Benefits of Genetic Addiction Risk Score (GARS?) Testing in Substance Use Disorder (SUD). Int J Genom Data Min. 2018; 2018(1).

View in: PubMed

authors with profiles

Marjorie C. Gondre-Lewis

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support